<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7112568\results\search\disease\results.xml">
  <result pre=": Article Specificity, kinetics and longevity of antibody responses to" exact="avian influenza" post="A(H7N9) virus infection in humans ChenJunboa1ZhuHuachenbc1HorbyPeter W.dWangQianliaZhouJiaxinaJiangHuiefLiuLiweibZhangTianchengZhangYonglihChenXinhuaaDengXiaoweiaNikolayBirgitiWangWeiaCauchemezSimoniGuanYibcUyekiTimothy M.jYuHongjieyhj@fudan.edu.cna�?�[a], [b],"/>
  <result pre="Article Specificity, kinetics and longevity of antibody responses to avian" exact="influenza" post="A(H7N9) virus infection in humans ChenJunboa1ZhuHuachenbc1HorbyPeter W.dWangQianliaZhouJiaxinaJiangHuiefLiuLiweibZhangTianchengZhangYonglihChenXinhuaaDengXiaoweiaNikolayBirgitiWangWeiaCauchemezSimoniGuanYibcUyekiTimothy M.jYuHongjieyhj@fudan.edu.cna�?�[a], [b],"/>
  <result pre="Objectives The long-term dynamics of antibody responses in patients with" exact="influenza" post="A(H7N9) virus infection are not well understood. Methods We"/>
  <result pre="were significantly higher in patients who experienced severe disease, including" exact="respiratory failure" post="and acute respiratory distress syndrome, compared with patients who"/>
  <result pre="in patients who experienced severe disease, including respiratory failure and" exact="acute respiratory distress syndrome," post="compared with patients who experienced less severe illness. Conclusions"/>
  <result pre="response Clinical severity Follow-up Influenza A(H7N9) Introduction Human infections with" exact="avian influenza" post="A(H7N9) virus were first identified in the spring of"/>
  <result pre="Clinical severity Follow-up Influenza A(H7N9) Introduction Human infections with avian" exact="influenza" post="A(H7N9) virus were first identified in the spring of"/>
  <result pre="2013 in China,1 causing more human infections than any other" exact="avian influenza" post="A virus.2 As of July 1, 2019, a total"/>
  <result pre="in China,1 causing more human infections than any other avian" exact="influenza" post="A virus.2 As of July 1, 2019, a total"/>
  <result pre="evolved into antigenically distinct strains during 2016–2017, including low pathogenic" exact="avian influenza" post="(LPAI) A(H7N9) virus strains (represented by A/Hong Kong/125/2017), and"/>
  <result pre="into antigenically distinct strains during 2016–2017, including low pathogenic avian" exact="influenza" post="(LPAI) A(H7N9) virus strains (represented by A/Hong Kong/125/2017), and"/>
  <result pre="A/Hong Kong/125/2017), and some viruses were classified as highly pathogenic" exact="avian influenza" post="(HPAI) strains based on their genotype (represented by A/Guangdong/17SF003/2016).7"/>
  <result pre="Kong/125/2017), and some viruses were classified as highly pathogenic avian" exact="influenza" post="(HPAI) strains based on their genotype (represented by A/Guangdong/17SF003/2016).7"/>
  <result pre="moderate to high public health risk, ranking highest among 12" exact="influenza" post="A viruses of animal-origin in the United States Centers"/>
  <result pre="in the United States Centers for Disease Control and Prevention" exact="influenza" post="risk assessment tool.11 Most laboratory-confirmed cases of A(H7N9) virus"/>
  <result pre="the emergence of neuraminidase inhibitor resistance in A(H7N9) and other" exact="avian influenza" post="A viruses highlights the need for additional therapeutic options.13"/>
  <result pre="emergence of neuraminidase inhibitor resistance in A(H7N9) and other avian" exact="influenza" post="A viruses highlights the need for additional therapeutic options.13"/>
  <result pre="first randomized controlled trial of immune plasma in severe seasonal" exact="influenza" post="and reported evidence of clinical benefit, primarily limited to"/>
  <result pre="case-to-case heterogeneity in antibody titers, and the rapid evolution of" exact="influenza" post="viruses.19 Limited understanding of the specificity, kinetics, and duration"/>
  <result pre="followed patients with reverse transcription polymerase chain reaction (RT-PCR) confirmed" exact="influenza" post="A(H7N9) virus infection from six provinces of China (Beijing,"/>
  <result pre="Underlying medical conditions associated with high risk for complications of" exact="influenza" post="were defined as reported previously.22 Patients were classified as"/>
  <result pre="were classified as having severe illness if they experienced the" exact="acute respiratory distress syndrome" post="(ARDS) or required mechanical ventilation. For patients who were"/>
  <result pre="high-risk chronic medical condition. The most common clinical complications included" exact="pneumonia" post="(84%), respiratory failure (49%), and ARDS (46%). Forty-one percent"/>
  <result pre="medical condition. The most common clinical complications included pneumonia (84%)," exact="respiratory failure" post="(49%), and ARDS (46%). Forty-one percent of patients required"/>
  <result pre="otherwise indicated. IQR=interquartile range. ARDS=acute respiratory distress syndrome. aIncludes chronic" exact="cardiovascular disease" post="(17), type 1 or 2 diabetes (6), chronic respiratory"/>
  <result pre="cardiovascular disease (17), type 1 or 2 diabetes (6), chronic" exact="respiratory disease" post="(2), neurological disease (2), chronic liver disease (1), chronic"/>
  <result pre="diabetes (6), chronic respiratory disease (2), neurological disease (2), chronic" exact="liver disease" post="(1), chronic renal disease (1), and anemia (1), these"/>
  <result pre="(2), chronic liver disease (1), chronic renal disease (1), and" exact="anemia" post="(1), these underlying medical conditions are not mutually exclusive."/>
  <result pre="cross-reactive T cell memory is important for protection against severe" exact="influenza" post="disease caused by newly emerging influenza A viruses.38, 39,"/>
  <result pre="for protection against severe influenza disease caused by newly emerging" exact="influenza" post="A viruses.38, 39, 40 Therefore, lack of sufficient T"/>
  <result pre="vaccines induce comparable levels of HA-reactive IgG antibody as seasonal" exact="influenza" post="vaccines in mice, but neutralizing titers are low, suggesting"/>
  <result pre="variety of emerging infectious diseases,44 including 1918 H1N1 pandemic influenza,14" exact="influenza" post="A(H5N1),17,18 influenza A(H1N1)pdm09,45 and severe acute respiratory syndrome (SARS).46"/>
  <result pre="emerging infectious diseases,44 including 1918 H1N1 pandemic influenza,14 influenza A(H5N1),17,18" exact="influenza" post="A(H1N1)pdm09,45 and severe acute respiratory syndrome (SARS).46 Timely treatment"/>
  <result pre="including 1918 H1N1 pandemic influenza,14 influenza A(H5N1),17,18 influenza A(H1N1)pdm09,45 and" exact="severe acute respiratory syndrome" post="(SARS).46 Timely treatment of patients with severe A(H1N1)pdm09 illness"/>
  <result pre="implementation of a passive-immunotherapy program is logistically feasible during an" exact="influenza" post="pandemic.48 Kreil et al. demonstrated the feasibility of producing"/>
  <result pre="research funds are related to research on human infections with" exact="avian influenza" post="A viruses. All other authors declare no competing interests."/>
  <result pre="funds are related to research on human infections with avian" exact="influenza" post="A viruses. All other authors declare no competing interests."/>
  <result pre="other authors declare no competing interests. References References 1WangX.JiangH.WuP.UyekiT.M.FengL.LaiS.Epidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
  <result pre="authors declare no competing interests. References References 1WangX.JiangH.WuP.UyekiT.M.FengL.LaiS.Epidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
  <result pre="from emerging and re-emerging pathogensCell17220181157115910.1016/j.cell.2018.02.02529522735 3YuD.XiangG.ZhuW.LeiX.LiB.MengY.The re-emergence of highly pathogenic" exact="avian influenza" post="H7N9 viruses in humans in Mainland China, 2019Euro Surveill"/>
  <result pre="emerging and re-emerging pathogensCell17220181157115910.1016/j.cell.2018.02.02529522735 3YuD.XiangG.ZhuW.LeiX.LiB.MengY.The re-emergence of highly pathogenic avian" exact="influenza" post="H7N9 viruses in humans in Mainland China, 2019Euro Surveill"/>
  <result pre="Commun Dis Bull20192410.2807/1560-7917.es.2019.24.21.1900273 4collab: WHOAntigenic and genetic characteristics of zoonotic" exact="influenza" post="viruses and development of candidate vaccine viruses for pandemic"/>
  <result pre="Record942019151160 5KileJ.C.RenR.LiuL.GreeneC.M.RoguskiK.IulianoA.D.Update: increase in human infections with novel Asian lineage" exact="avian influenza" post="A(H7N9) viruses during the fifth epidemic – China, October"/>
  <result pre="5KileJ.C.RenR.LiuL.GreeneC.M.RoguskiK.IulianoA.D.Update: increase in human infections with novel Asian lineage avian" exact="influenza" post="A(H7N9) viruses during the fifth epidemic – China, October"/>
  <result pre="7, 2017MMWR Morb Mortal Wkly Rep66201792893210.15585/mmwr.mm6635a228880856 6WangD.YangL.ZhuW.ZhangY.ZouS.BoH.Two outbreak sources of" exact="influenza" post="a (H7N9) viruses have been established in chinaJ Virol9020165561557310.1128/jvi.03173-1527030268"/>
  <result pre="(H7N9) viruses have been established in chinaJ Virol9020165561557310.1128/jvi.03173-1527030268 7collab: WHOZoonotic" exact="influenza" post="viruses: antigenic and genetic characteristics and development of candidate"/>
  <result pre="between human infections caused by highly and low pathogenic H7N9" exact="avian influenza" post="viruses in wave five: clinical and virological findingsJ Infect78201924124810.1016/j.jinf.2019.01.00530664912"/>
  <result pre="human infections caused by highly and low pathogenic H7N9 avian" exact="influenza" post="viruses in wave five: clinical and virological findingsJ Infect78201924124810.1016/j.jinf.2019.01.00530664912"/>
  <result pre="Host Microbe24201855856810.1016/j.chom.2018.08.006e730269969 11Centers for Disease Control and Prevention. Summary of" exact="influenza" post="risk assessment tool (IRAT) results. Available at:https://www.cdc.gov/flu/pandemic-resources/monitoring/irat-virus-summaries.htm. Accessed 1"/>
  <result pre="early initiation of neuraminidase inhibitor treatment to hospitalized patients with" exact="avian influenza" post="A(H7N9) virusClin Infect Dis Off Publ Infect Dis Soc"/>
  <result pre="initiation of neuraminidase inhibitor treatment to hospitalized patients with avian" exact="influenza" post="A(H7N9) virusClin Infect Dis Off Publ Infect Dis Soc"/>
  <result pre="between adverse clinical outcome in human disease caused by novel" exact="influenza" post="A H7N9 virus and sustained viral shedding and emergence"/>
  <result pre="emergence of antiviral resistanceLancet38120132273227910.1016/s0140-6736(13)61125-323726392 14LukeT.C.KilbaneE.M.JacksonJ.L.HoffmanS.L.Meta-analysis: convalescent blood products for Spanish" exact="influenza" post="pneumonia: a future H5N1 treatment?Ann Intern Med145200659960916940336 15BeigelJ.H.TebasP.Elie-TurenneM.C.BajwaE.BellT.E.CairnsC.B.Immune plasma"/>
  <result pre="phase 2 randomised studyLancet Respir Med5201750051110.1016/s2213-2600(17)30174-128522352 16WuX.X.GaoH.N.WuH.B.PengX.M.OuH.L.LiL.J.Successful treatment of avian-origin" exact="influenza" post="A (H7N9) infection using convalescent plasmaInt J Infect Dis"/>
  <result pre="Dis4120153510.1016/j.ijid.2015.10.009 17YuH.GaoZ.FengZ.ShuY.XiangN.ZhouL.Clinical characteristics of 26 human cases of highly pathogenic" exact="avian influenza" post="A (H5N1) virus infection in ChinaPLoS One32008e298510.1371/journal.pone.000298518716658 18WangH.FengZ.ShuY.YuH.ZhouL.ZuR.Probable limited"/>
  <result pre="17YuH.GaoZ.FengZ.ShuY.XiangN.ZhouL.Clinical characteristics of 26 human cases of highly pathogenic avian" exact="influenza" post="A (H5N1) virus infection in ChinaPLoS One32008e298510.1371/journal.pone.000298518716658 18WangH.FengZ.ShuY.YuH.ZhouL.ZuR.Probable limited"/>
  <result pre="in ChinaPLoS One32008e298510.1371/journal.pone.000298518716658 18WangH.FengZ.ShuY.YuH.ZhouL.ZuR.Probable limited person-to-person transmission of highly pathogenic" exact="avian influenza" post="A (H5N1) virus in ChinaLancet37120081427143410.1016/s0140-6736(08)60493-618400288 19LeeN.HuiD.S.C.Potential and challenges of"/>
  <result pre="ChinaPLoS One32008e298510.1371/journal.pone.000298518716658 18WangH.FengZ.ShuY.YuH.ZhouL.ZuR.Probable limited person-to-person transmission of highly pathogenic avian" exact="influenza" post="A (H5N1) virus in ChinaLancet37120081427143410.1016/s0140-6736(08)60493-618400288 19LeeN.HuiD.S.C.Potential and challenges of"/>
  <result pre="T.M., Mootrey G., et al. Prevention and control of seasonal" exact="influenza" post="with vaccines: recommendations of the Advisory Committee on Immunization"/>
  <result pre="23ZhaoM.ChenJ.TanS.DongT.JiangH.ZhengJ.Prolonged evolution of virus-specific memory T cell immunity post severe" exact="avian influenza" post="A (H7N9) virus infectionJ Virol201810.1128/jvi.01024-18 24collab: WHOZoonotic influenza viruses:"/>
  <result pre="evolution of virus-specific memory T cell immunity post severe avian" exact="influenza" post="A (H7N9) virus infectionJ Virol201810.1128/jvi.01024-18 24collab: WHOZoonotic influenza viruses:"/>
  <result pre="severe avian influenza A (H7N9) virus infectionJ Virol201810.1128/jvi.01024-18 24collab: WHOZoonotic" exact="influenza" post="viruses: antigenic and genetic characteristics and development of candidate"/>
  <result pre="preparednessWkly Epidemiol Rec92201763364829052410 25collab: WHOAntigenic and genetic characteristics of zoonotic" exact="influenza" post="viruses and development of candidate vaccine viruses for pandemic"/>
  <result pre="pandemic preparednessWkly Epidemiol Rec89201445746425337626 26LuJ.RaghwaniJ.PryceR.BowdenT.A.ThezeJ.HuangS.Molecular evolution, diversity, and adaptation of" exact="influenza" post="A(H7N9) viruses in ChinaEmerging Infect Dis2420181795180510.3201/eid2410.17106330226157 27World Health Organization."/>
  <result pre="ChinaEmerging Infect Dis2420181795180510.3201/eid2410.17106330226157 27World Health Organization. WHO manual on animal" exact="influenza" post="diagnosis and surveillance. 2002; Available at:http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf. Accessed 1 July"/>
  <result pre="combination of serological assays to detect human antibodies to the" exact="avian influenza" post="A H7N9 virusPLoS One92014e9561210.1371/journal.pone.009561224755627 30BuchyP.VongS.ChuS.GarciaJ.M.HienT.T.HienV.M.Kinetics of neutralizing antibodies in"/>
  <result pre="of serological assays to detect human antibodies to the avian" exact="influenza" post="A H7N9 virusPLoS One92014e9561210.1371/journal.pone.009561224755627 30BuchyP.VongS.ChuS.GarciaJ.M.HienT.T.HienV.M.Kinetics of neutralizing antibodies in"/>
  <result pre="naturally infected by H5N1 virusPLoS One52010e1086410.1371/journal.pone.001086420532246 31GuoL.ZhangX.RenL.YuX.ChenL.ZhouH.Human antibody responses to" exact="avian influenza" post="A(H7N9) virus, 2013Emerging Infect Dis20201419220010.3201/eid2002.13109424447423 32LeeA.C.ZhuH.ZhangA.J.LiC.WangP.LiC.Suboptimal humoral immune response"/>
  <result pre="infected by H5N1 virusPLoS One52010e1086410.1371/journal.pone.001086420532246 31GuoL.ZhangX.RenL.YuX.ChenL.ZhouH.Human antibody responses to avian" exact="influenza" post="A(H7N9) virus, 2013Emerging Infect Dis20201419220010.3201/eid2002.13109424447423 32LeeA.C.ZhuH.ZhangA.J.LiC.WangP.LiC.Suboptimal humoral immune response"/>
  <result pre="A(H7N9) virus, 2013Emerging Infect Dis20201419220010.3201/eid2002.13109424447423 32LeeA.C.ZhuH.ZhangA.J.LiC.WangP.LiC.Suboptimal humoral immune response against" exact="influenza" post="A(H7N9) virus is related to its internal genesClin Vacc"/>
  <result pre="is related to its internal genesClin Vacc Immunol: CVI2220151235124310.1128/cvi.00443-15 33YangS.ChenY.CuiD.YaoH.LouJ.HuoZ.Avian-origin" exact="influenza" post="A(H7N9) infection in influenza A(H7N9)-affected areas of China: a"/>
  <result pre="internal genesClin Vacc Immunol: CVI2220151235124310.1128/cvi.00443-15 33YangS.ChenY.CuiD.YaoH.LouJ.HuoZ.Avian-origin influenza A(H7N9) infection in" exact="influenza" post="A(H7N9)-affected areas of China: a serological studyJ Infect Dis209201426526910.1093/infdis/jit43023935201"/>
  <result pre="a serological studyJ Infect Dis209201426526910.1093/infdis/jit43023935201 34ZhangA.HuangY.TianD.LauE.H.WanY.LiuX.Kinetics of serological responses in" exact="influenza" post="A(H7N9)-infected patients correlate with clinical outcome in China, 2013Euro"/>
  <result pre="2013Euro Surveill Bull Eur Mal Transm = Eur Commun Dis Bull18201320657 35YangP.MaC.CuiS.ZhangD.ShiW.PanY.Avian" exact="influenza" post="A(H7N9) and (H5N1) infections among poultry and swine workers"/>
  <result pre="and the general population in Beijing, China, 2013–2015Sci Rep620163387710.1038/srep3387727670286 36MaM.J.ZhaoT.ChenS.H.XiaX.YangX.X.WangG.L.Avian" exact="influenza" post="A virus infection among workers at live poultry markets,"/>
  <result pre="live poultry markets, China, 2013–2016Emerging Infect Dis2420181246125610.3201/eid2407.17205929912708 37FreemanG.CowlingB.J.Serological responses following" exact="influenza" post="A(H7N9) virus infectionJ Infect Dis20920142018201910.1093/infdis/jiu02124415788 38WangZ.WanY.QiuC.Quinones-ParraS.ZhuZ.LohL.Recovery from severe H7N9"/>
  <result pre="outcomes in human H7N9 infectionJ Infect69201435836510.1016/j.jinf.2014.05.00624841136 41WangW.PengH.TaoQ.ZhaoX.TangH.TangZ.Serologic assay for avian-origin" exact="influenza" post="A (H7N9) virus in adults of Shanghai, Guangzhou and"/>
  <result pre="Virol: Off Publ Pan Am Soc Clin Virol60201430530810.1016/j.jcv.2014.04.006 42KamalR.P.BlanchfieldK.BelserJ.A.MusicN.TzengW.P.HolidayC.Inactivated H7" exact="influenza" post="virus vaccines protect mice despite inducing only low levels"/>
  <result pre="neutralizing antibodiesJ Virol91201710.1128/jvi.01202-17 43Henry DunandC.J.LeonP.E.HuangM.ChoiA.ChromikovaV.HoI.Y.Both neutralizing and non-neutralizing human H7N9" exact="influenza" post="vaccine-induced monoclonal antibodies confer protectionCell Host Microbe19201680081310.1016/j.chom.2016.05.01427281570 44CasadevallA.DadachovaE.PirofskiL.A.Passive antibody"/>
  <result pre="45HungI.F.ToK.K.LeeC.K.LeeK.L.ChanK.YanW.W.Convalescent plasma treatment reduced mortality in patients with severe pandemic" exact="influenza" post="A (H1N1) 2009 virus infectionClin Infect Dis: Off Publ"/>
  <result pre="multicenter double-blind randomized controlled trial for patients with severe 2009" exact="influenza" post="A(H1N1) infectionChest144201346447310.1378/chest.12-290723450336 48WuJ.T.LeeC.K.CowlingB.J.YuenK.Y.Logistical feasibility and potential benefits of a"/>
  <result pre="and potential benefits of a population-wide passive-immunotherapy program during an" exact="influenza" post="pandemicProc Natl Acad Sci USA10720103269327410.1073/pnas.091159610720133660 49KreilT.R.Mc VeyJ.K.LeiL.S.CamachoL.WodalW.KerschbaumA.Preparation of commercial"/>
  <result pre="convalescent plasma collection: a case scenario in pandemic preparation for" exact="influenza" post="A (H1N1) infectionTransfusion5020101967197110.1111/j.1537-2995.2010.02651.x20412524 52WangY.GuoQ.YanZ.ZhouD.ZhangW.ZhouS.Factors associated with prolonged viral shedding"/>
  <result pre="infectionTransfusion5020101967197110.1111/j.1537-2995.2010.02651.x20412524 52WangY.GuoQ.YanZ.ZhouD.ZhangW.ZhouS.Factors associated with prolonged viral shedding in patients with" exact="avian influenza" post="A(H7N9) virus infectionJ Infect Dis21720181708171710.1093/infdis/jiy11529648602 53YangY.ZhongH.SongT.HeJ.GuoL.TanX.Epidemiological and clinical characteristics"/>
  <result pre="52WangY.GuoQ.YanZ.ZhouD.ZhangW.ZhouS.Factors associated with prolonged viral shedding in patients with avian" exact="influenza" post="A(H7N9) virus infectionJ Infect Dis21720181708171710.1093/infdis/jiy11529648602 53YangY.ZhongH.SongT.HeJ.GuoL.TanX.Epidemiological and clinical characteristics"/>
  <result pre="infectionJ Infect Dis21720181708171710.1093/infdis/jiy11529648602 53YangY.ZhongH.SongT.HeJ.GuoL.TanX.Epidemiological and clinical characteristics of humans with" exact="avian influenza" post="A (H7N9) infection in Guangdong, China, 2013-2017Int J Infect"/>
  <result pre="Infect Dis21720181708171710.1093/infdis/jiy11529648602 53YangY.ZhongH.SongT.HeJ.GuoL.TanX.Epidemiological and clinical characteristics of humans with avian" exact="influenza" post="A (H7N9) infection in Guangdong, China, 2013-2017Int J Infect"/>
  <result pre="July 2019. 55JacksonL.A.CampbellJ.D.FreyS.E.EdwardsK.M.KeitelW.A.KotloffK.L.Effect of varying doses of a monovalent H7N9" exact="influenza" post="vaccine with and without AS03 and MF59 adjuvants on"/>
 </snippets>
</snippetsTree>
